Independent HPLC result for Tirzepatide 60 mg, batch 07/2026: 99.408% purity, tested by Janoshik Analytical on 31 August 2026.
This is the public record for Tirzepatide 60 mg, batch 07/2026. The batch was tested by Janoshik Analytical, an independent laboratory that publishes every report on its own website, so you don’t have to take our word for the result.
| Product | Tirzepatide 60 mg pen |
|---|---|
| Batch number | 07/2026 |
| Laboratory | Janoshik Analytical |
| Report number | Task #224433 |
| Method | HPLC (high-performance liquid chromatography) |
| Purity | 99.408% |
| Measured content | 25.93 mg/ml |
| Analysis date | 31 August 2026 |
View the original report on janoshik.com → Download the certificate (PDF)

If anything doesn’t match, contact us with your order number and a photo of the label.
Purity is the share of the sample that HPLC identifies as tirzepatide. 99.408% means the remaining fraction is made up of related peptide fragments and other minor components.
Measured content is the concentration of tirzepatide in the pen’s solution, in milligrams per millilitre. It is a laboratory measurement of the material, not a dose.
For a fuller walk-through, read how to read a Certificate of Analysis.
Supplied strictly for laboratory research use. Not for human or veterinary use.